August 2020 - Volume 5 - Issue 4 - Contributor Index

Alphabetical Search
D
G
H
J
O
Q
R
U
V
X
Z

Exploratory retrospective study of risk factors for thromboembolism treated with multi-kinase inhibitor pazopanib or lenvatinib

Nio, Kenta; Tsuchihashi, Kenji; Taguchi, Keisuke; More

International Journal of Surgery Oncology. 5(4):e89, August 2020.

Exploratory retrospective study of risk factors for thromboembolism treated with multi-kinase inhibitor pazopanib or lenvatinib

Nio, Kenta; Tsuchihashi, Kenji; Taguchi, Keisuke; More

International Journal of Surgery Oncology. 5(4):e89, August 2020.

Exploratory retrospective study of risk factors for thromboembolism treated with multi-kinase inhibitor pazopanib or lenvatinib

Nio, Kenta; Tsuchihashi, Kenji; Taguchi, Keisuke; More

International Journal of Surgery Oncology. 5(4):e89, August 2020.

Author:
Chau, Bonny MPH

Impact of nodal involvement on survival outcomes in chondrosarcoma: retrospective cohort analysis of Surveillance, Epidemiology, and End Results (SEER) database (2004–2015)

Cranmer, Lee D.; Chau, Bonny; Thompson, Matthew J.; More

International Journal of Surgery Oncology. 5(4):, August 2020.

Impact of nodal involvement on survival outcomes in chondrosarcoma: retrospective cohort analysis of Surveillance, Epidemiology, and End Results (SEER) database (2004–2015)

Cranmer, Lee D.; Chau, Bonny; Thompson, Matthew J.; More

International Journal of Surgery Oncology. 5(4):, August 2020.

Exploratory retrospective study of risk factors for thromboembolism treated with multi-kinase inhibitor pazopanib or lenvatinib

Nio, Kenta; Tsuchihashi, Kenji; Taguchi, Keisuke; More

International Journal of Surgery Oncology. 5(4):e89, August 2020.

Exploratory retrospective study of risk factors for thromboembolism treated with multi-kinase inhibitor pazopanib or lenvatinib

Nio, Kenta; Tsuchihashi, Kenji; Taguchi, Keisuke; More

International Journal of Surgery Oncology. 5(4):e89, August 2020.

Exploratory retrospective study of risk factors for thromboembolism treated with multi-kinase inhibitor pazopanib or lenvatinib

Nio, Kenta; Tsuchihashi, Kenji; Taguchi, Keisuke; More

International Journal of Surgery Oncology. 5(4):e89, August 2020.

Exploratory retrospective study of risk factors for thromboembolism treated with multi-kinase inhibitor pazopanib or lenvatinib

Nio, Kenta; Tsuchihashi, Kenji; Taguchi, Keisuke; More

International Journal of Surgery Oncology. 5(4):e89, August 2020.

Impact of nodal involvement on survival outcomes in chondrosarcoma: retrospective cohort analysis of Surveillance, Epidemiology, and End Results (SEER) database (2004–2015)

Cranmer, Lee D.; Chau, Bonny; Thompson, Matthew J.; More

International Journal of Surgery Oncology. 5(4):, August 2020.

Impact of nodal involvement on survival outcomes in chondrosarcoma: retrospective cohort analysis of Surveillance, Epidemiology, and End Results (SEER) database (2004–2015)

Cranmer, Lee D.; Chau, Bonny; Thompson, Matthew J.; More

International Journal of Surgery Oncology. 5(4):, August 2020.

Impact of nodal involvement on survival outcomes in chondrosarcoma: retrospective cohort analysis of Surveillance, Epidemiology, and End Results (SEER) database (2004–2015)

Cranmer, Lee D.; Chau, Bonny; Thompson, Matthew J.; More

International Journal of Surgery Oncology. 5(4):, August 2020.

Exploratory retrospective study of risk factors for thromboembolism treated with multi-kinase inhibitor pazopanib or lenvatinib

Nio, Kenta; Tsuchihashi, Kenji; Taguchi, Keisuke; More

International Journal of Surgery Oncology. 5(4):e89, August 2020.

Exploratory retrospective study of risk factors for thromboembolism treated with multi-kinase inhibitor pazopanib or lenvatinib

Nio, Kenta; Tsuchihashi, Kenji; Taguchi, Keisuke; More

International Journal of Surgery Oncology. 5(4):e89, August 2020.

Impact of nodal involvement on survival outcomes in chondrosarcoma: retrospective cohort analysis of Surveillance, Epidemiology, and End Results (SEER) database (2004–2015)

Cranmer, Lee D.; Chau, Bonny; Thompson, Matthew J.; More

International Journal of Surgery Oncology. 5(4):, August 2020.

Exploratory retrospective study of risk factors for thromboembolism treated with multi-kinase inhibitor pazopanib or lenvatinib

Nio, Kenta; Tsuchihashi, Kenji; Taguchi, Keisuke; More

International Journal of Surgery Oncology. 5(4):e89, August 2020.

Exploratory retrospective study of risk factors for thromboembolism treated with multi-kinase inhibitor pazopanib or lenvatinib

Nio, Kenta; Tsuchihashi, Kenji; Taguchi, Keisuke; More

International Journal of Surgery Oncology. 5(4):e89, August 2020.

Exploratory retrospective study of risk factors for thromboembolism treated with multi-kinase inhibitor pazopanib or lenvatinib

Nio, Kenta; Tsuchihashi, Kenji; Taguchi, Keisuke; More

International Journal of Surgery Oncology. 5(4):e89, August 2020.

Exploratory retrospective study of risk factors for thromboembolism treated with multi-kinase inhibitor pazopanib or lenvatinib

Nio, Kenta; Tsuchihashi, Kenji; Taguchi, Keisuke; More

International Journal of Surgery Oncology. 5(4):e89, August 2020.

Impact of nodal involvement on survival outcomes in chondrosarcoma: retrospective cohort analysis of Surveillance, Epidemiology, and End Results (SEER) database (2004–2015)

Cranmer, Lee D.; Chau, Bonny; Thompson, Matthew J.; More

International Journal of Surgery Oncology. 5(4):, August 2020.

Impact of nodal involvement on survival outcomes in chondrosarcoma: retrospective cohort analysis of Surveillance, Epidemiology, and End Results (SEER) database (2004–2015)

Cranmer, Lee D.; Chau, Bonny; Thompson, Matthew J.; More

International Journal of Surgery Oncology. 5(4):, August 2020.

Exploratory retrospective study of risk factors for thromboembolism treated with multi-kinase inhibitor pazopanib or lenvatinib

Nio, Kenta; Tsuchihashi, Kenji; Taguchi, Keisuke; More

International Journal of Surgery Oncology. 5(4):e89, August 2020.

Exploratory retrospective study of risk factors for thromboembolism treated with multi-kinase inhibitor pazopanib or lenvatinib

Nio, Kenta; Tsuchihashi, Kenji; Taguchi, Keisuke; More

International Journal of Surgery Oncology. 5(4):e89, August 2020.

Impact of nodal involvement on survival outcomes in chondrosarcoma: retrospective cohort analysis of Surveillance, Epidemiology, and End Results (SEER) database (2004–2015)

Cranmer, Lee D.; Chau, Bonny; Thompson, Matthew J.; More

International Journal of Surgery Oncology. 5(4):, August 2020.

Exploratory retrospective study of risk factors for thromboembolism treated with multi-kinase inhibitor pazopanib or lenvatinib

Nio, Kenta; Tsuchihashi, Kenji; Taguchi, Keisuke; More

International Journal of Surgery Oncology. 5(4):e89, August 2020.

Impact of nodal involvement on survival outcomes in chondrosarcoma: retrospective cohort analysis of Surveillance, Epidemiology, and End Results (SEER) database (2004–2015)

Cranmer, Lee D.; Chau, Bonny; Thompson, Matthew J.; More

International Journal of Surgery Oncology. 5(4):, August 2020.

Exploratory retrospective study of risk factors for thromboembolism treated with multi-kinase inhibitor pazopanib or lenvatinib

Nio, Kenta; Tsuchihashi, Kenji; Taguchi, Keisuke; More

International Journal of Surgery Oncology. 5(4):e89, August 2020.

Exploratory retrospective study of risk factors for thromboembolism treated with multi-kinase inhibitor pazopanib or lenvatinib

Nio, Kenta; Tsuchihashi, Kenji; Taguchi, Keisuke; More

International Journal of Surgery Oncology. 5(4):e89, August 2020.

Exploratory retrospective study of risk factors for thromboembolism treated with multi-kinase inhibitor pazopanib or lenvatinib

Nio, Kenta; Tsuchihashi, Kenji; Taguchi, Keisuke; More

International Journal of Surgery Oncology. 5(4):e89, August 2020.

Exploratory retrospective study of risk factors for thromboembolism treated with multi-kinase inhibitor pazopanib or lenvatinib

Nio, Kenta; Tsuchihashi, Kenji; Taguchi, Keisuke; More

International Journal of Surgery Oncology. 5(4):e89, August 2020.

Show: